Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000960309 | SCV001107274 | benign | not provided | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000960309 | SCV004146515 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | FBN3: BP4, BS2 |
Breakthrough Genomics, |
RCV000960309 | SCV005315232 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003926123 | SCV004739069 | likely benign | FBN3-related disorder | 2019-02-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |